Tur MK - Search Results

1

Molecular Targeting Therapy against EGFR Family in Breast Cancer: Progress and Future Potentials.

Maennling AE, Tur MK, Niebert M, Klockenbring T, Zeppernick F, Gattenlöhner S, Meinhold-Heerlein I, Hussain AF. Maennling AE, et al. Among authors: tur mk. Cancers (Basel). 2019 Nov 20;11(12):1826. doi: 10.3390/cancers11121826. Cancers (Basel). 2019. PMID: 31756933 Free PMC article. Review.

2

Elimination of HER3-expressing breast cancer cells using aptamer-siRNA chimeras.

Nachreiner I, Hussain AF, Wullner U, Machuy N, Meyer TF, Fischer R, Gattenlöhner S, Meinhold-Heerlein I, Barth S, Tur MK. Nachreiner I, et al. Among authors: tur mk. Exp Ther Med. 2019 Oct;18(4):2401-2412. doi: 10.3892/etm.2019.7753. Epub 2019 Jul 9. Exp Ther Med. 2019. PMID: 31555351 Free PMC article.

3

An aptamer-siRNA chimera silences the eukaryotic elongation factor 2 gene and induces apoptosis in cancers expressing αvβ3 integrin.

Hussain AF, Tur MK, Barth S. Hussain AF, et al. Among authors: tur mk. Nucleic Acid Ther. 2013 Jun;23(3):203-12. doi: 10.1089/nat.2012.0408. Epub 2013 Apr 1. Nucleic Acid Ther. 2013. PMID: 23544955

4

In vitro effects and ex vivo binding of an EGFR-specific immunotoxin on rhabdomyosarcoma cells.

Niesen J, Brehm H, Stein C, Berges N, Pardo A, Fischer R, Ten Haaf A, Gattenlöhner S, Tur MK, Barth S. Niesen J, et al. Among authors: tur mk. J Cancer Res Clin Oncol. 2015 Jun;141(6):1049-61. doi: 10.1007/s00432-014-1884-z. Epub 2014 Nov 30. J Cancer Res Clin Oncol. 2015. PMID: 25433506

5

Novel PSCA targeting scFv-fusion proteins for diagnosis and immunotherapy of prostate cancer.

Kessler C, Pardo A, Tur MK, Gattenlöhner S, Fischer R, Kolberg K, Barth S. Kessler C, et al. Among authors: tur mk. J Cancer Res Clin Oncol. 2017 Oct;143(10):2025-2038. doi: 10.1007/s00432-017-2472-9. Epub 2017 Jun 30. J Cancer Res Clin Oncol. 2017. PMID: 28667390

6

Antibody Selection on FFPE Tissue Slides.

Ten Haaf A, Gattenlöhner S, Tur MK. Ten Haaf A, et al. Among authors: tur mk. Methods Mol Biol. 2018;1701:381-391. doi: 10.1007/978-1-4939-7447-4_21. Methods Mol Biol. 2018. PMID: 29116517

7

The 140-kD isoform of CD56 (NCAM1) directs the molecular pathogenesis of ischemic cardiomyopathy.

Tur MK, Etschmann B, Benz A, Leich E, Waller C, Schuh K, Rosenwald A, Ertl G, Kienitz A, Haaf AT, Bräuninger A, Gattenlöhner S. Tur MK, et al. Am J Pathol. 2013 Apr;182(4):1205-18. doi: 10.1016/j.ajpath.2012.12.027. Epub 2013 Feb 8. Am J Pathol. 2013. PMID: 23462508 Free article.

8

SNAP-tag technology mediates site specific conjugation of antibody fragments with a photosensitizer and improves target specific phototoxicity in tumor cells.

Hussain AF, Kampmeier F, von Felbert V, Merk HF, Tur MK, Barth S. Hussain AF, et al. Among authors: tur mk. Bioconjug Chem. 2011 Dec 21;22(12):2487-95. doi: 10.1021/bc200304k. Epub 2011 Nov 3. Bioconjug Chem. 2011. PMID: 21995499

9

Phage display-based on-slide selection of tumor-specific antibodies on formalin-fixed paraffin-embedded human tissue biopsies.

Ten Haaf A, Pscherer S, Fries K, Barth S, Gattenlöhner S, Tur MK. Ten Haaf A, et al. Among authors: tur mk. Immunol Lett. 2015 Aug;166(2):65-78. doi: 10.1016/j.imlet.2015.05.013. Epub 2015 Jun 2. Immunol Lett. 2015. PMID: 26045318

10

Phage display-based generation of novel internalizing antibody fragments for immunotoxin-based treatment of acute myeloid leukemia.

Fitting J, Blume T, Ten Haaf A, Blau W, Gattenlöhner S, Tur MK, Barth S. Fitting J, et al. Among authors: tur mk. MAbs. 2015;7(2):390-402. doi: 10.1080/19420862.2015.1007818. MAbs. 2015. PMID: 25760770 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters